| Forrest Duen-huei Hsu, MD | |
|
1717 13th St Ste 401, Everett, WA 98201 | |
| (425) 297-6400 | |
| Not Available |
| Full Name | Forrest Duen-huei Hsu |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 20 Years |
| Location | 1717 13th St Ste 401, Everett, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346546322 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD60788079 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Regional Medical Center Everett | Everett, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services- Washington | 8325100480 | 420 |
News Archive
Federal scientists have developed a vaccine that protects mice against the killer 1918 influenza virus. They also have created a technique for identifying antibodies that neutralize this virus, a tool that could help contain future pandemic flu strains.
Two research papers have been released that show that the abstinence-only-until-marriage (AOUM) programs and policies in the United States are ineffective by and large and have not been successful in reducing risky sexual behaviors or early initiation of sex. Studies have reported that these are programs that successfully withhold medically accurate information not to mention infringe on adolescent human rights and reinforce gender stereotypes. The findings are published in the Journal of Adolescent Health.
Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its analysis of proprietary late clinical stage NBN-Pac formulations, namely IG-001 (Cynviloq) and IG-004 (a D-a-tocopheryl polyethylene glycol succinate (TPGS)-based paclitaxel formulation) at the annual Nanomedicine 2013 meeting in Barcelona, Spain (April 11th - 12th).
The value of the biosimilars market segment will account for 2.6% of the biological market by 2016, forecasts a new report from URCH Publishing. However, this forecast assumes biosimilars become permitted under U.S. law by 2012, notes the market strategy report "Biosimilars: A Growing Market - An overview of developments, companies & commercial opportunities".
With $3.8 million in support from the National Institute on Aging, University of California, Irvine neurobiologists are working to identify the early indicators of dementia in older adults as disease-related brain plaques accumulate but before symptoms can be observed.
› Verified 7 days ago
| Entity Name | Providence Health & Services- Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124270715 PECOS PAC ID: 8325100480 Enrollment ID: O20081224000111 |
News Archive
Federal scientists have developed a vaccine that protects mice against the killer 1918 influenza virus. They also have created a technique for identifying antibodies that neutralize this virus, a tool that could help contain future pandemic flu strains.
Two research papers have been released that show that the abstinence-only-until-marriage (AOUM) programs and policies in the United States are ineffective by and large and have not been successful in reducing risky sexual behaviors or early initiation of sex. Studies have reported that these are programs that successfully withhold medically accurate information not to mention infringe on adolescent human rights and reinforce gender stereotypes. The findings are published in the Journal of Adolescent Health.
Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its analysis of proprietary late clinical stage NBN-Pac formulations, namely IG-001 (Cynviloq) and IG-004 (a D-a-tocopheryl polyethylene glycol succinate (TPGS)-based paclitaxel formulation) at the annual Nanomedicine 2013 meeting in Barcelona, Spain (April 11th - 12th).
The value of the biosimilars market segment will account for 2.6% of the biological market by 2016, forecasts a new report from URCH Publishing. However, this forecast assumes biosimilars become permitted under U.S. law by 2012, notes the market strategy report "Biosimilars: A Growing Market - An overview of developments, companies & commercial opportunities".
With $3.8 million in support from the National Institute on Aging, University of California, Irvine neurobiologists are working to identify the early indicators of dementia in older adults as disease-related brain plaques accumulate but before symptoms can be observed.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Forrest Duen-huei Hsu, MD Po Box 3360, Portland, OR 97208-3360 Ph: () - | Forrest Duen-huei Hsu, MD 1717 13th St Ste 401, Everett, WA 98201 Ph: (425) 297-6400 |
News Archive
Federal scientists have developed a vaccine that protects mice against the killer 1918 influenza virus. They also have created a technique for identifying antibodies that neutralize this virus, a tool that could help contain future pandemic flu strains.
Two research papers have been released that show that the abstinence-only-until-marriage (AOUM) programs and policies in the United States are ineffective by and large and have not been successful in reducing risky sexual behaviors or early initiation of sex. Studies have reported that these are programs that successfully withhold medically accurate information not to mention infringe on adolescent human rights and reinforce gender stereotypes. The findings are published in the Journal of Adolescent Health.
Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its analysis of proprietary late clinical stage NBN-Pac formulations, namely IG-001 (Cynviloq) and IG-004 (a D-a-tocopheryl polyethylene glycol succinate (TPGS)-based paclitaxel formulation) at the annual Nanomedicine 2013 meeting in Barcelona, Spain (April 11th - 12th).
The value of the biosimilars market segment will account for 2.6% of the biological market by 2016, forecasts a new report from URCH Publishing. However, this forecast assumes biosimilars become permitted under U.S. law by 2012, notes the market strategy report "Biosimilars: A Growing Market - An overview of developments, companies & commercial opportunities".
With $3.8 million in support from the National Institute on Aging, University of California, Irvine neurobiologists are working to identify the early indicators of dementia in older adults as disease-related brain plaques accumulate but before symptoms can be observed.
› Verified 7 days ago
James Michael Geier, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1330 Rockefeller Ave, Suite 220, Everett, WA 98201 Phone: 425-261-4920 Fax: 425-261-4988 | |
Daniel Alexander Clayton, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1717 13th St, Suite 401, Everett, WA 98201 Phone: 425-297-6400 Fax: 425-297-6405 | |
James J Wang, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1321 Colby Avle, Medical Staff Office, Everett, WA 98201 Phone: 425-261-2000 | |
Sanford J Wright Jr., MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 3726 Broadway Ste 201, Everett, WA 98201 Phone: 425-317-9119 Fax: 425-317-9118 | |
Dr. Martin Carlos Holland, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1717 13th St Ste 401, Everett, WA 98201 Phone: 425-297-6400 | |
Dr. Ruth Thiex, M.D. PH.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1717 13th St, Ste 401, Everett, WA 98201 Phone: 425-297-6400 |